Osteonecrose da cabeça femoral por uso de corticosteroides no tratamento da COVID-19: relato de caso

Non-traumatic osteonecrosis of the femoral head (ONHF) is characterized by cell death of osteocytes and alterations in osteoblasts and osteoclasts, often caused by prolonged use of corticosteroids. Other risk factors include autoimmune diseases, alcohol, radiotherapy and infections. This report describes the case of a 55-year-old man who developed ONHF after treatment with corticosteroids for COVID-19. ONHF can be insidious, manifesting with pain and limited movement, with magnetic resonance imaging (MRI) being the most effective diagnostic method. Treatment varies from conservative to surgical, depending on the stage of the disease. Early diagnosis and multidisciplinary follow-up are essential for a better prognosis. Future research should focus on developing COVID-19 treatment guidelines that reduce the incidence of ONCF, exploring safe and effective therapeutic alternatives.

Authors

Institutions

Publication Details

Journal
Revista de Medicina
Published
2024-08-29
DOI
https://doi.org/10.11606/issn.1679-9836.v103i4e-204032
Primary Topic
Bone and Joint Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Osteonecrose da cabeça femoral por uso de corticosteroides no tratamento da COVID-19: relato de caso

Lucas Hiron Ulhoa Carvalho, Mateus Gonçalves de Sena Barbosa, Rafaela Luiza Vilela de Souza, A Cordeiro et al.
Revista de Medicina
Bone and Joint Diseases
article

Osteonecrose da cabeça femoral por uso de corticosteroides no tratamento da COVID-19: relato de caso

Lucas Hiron Ulhoa Carvalho, Mateus Gonçalves de Sena Barbosa, Rafaela Luiza Vilela de Souza, A Cordeiro, J. M. Silva, Luiz Gabriel Gonçalves Cherain, Raphael Antunes Lacerda, Arthur Carvalho de Oliveira Gonçalves, Maria Eduarda Santos Affi Peixoto
article en

Abstract

Non-traumatic osteonecrosis of the femoral head (ONHF) is characterized by cell death of osteocytes and alterations in osteoblasts and osteoclasts, often caused by prolonged use of corticosteroids. Other risk factors include autoimmune diseases, alcohol, radiotherapy and infections. This report describes the case of a 55-year-old man who developed ONHF after treatment with corticosteroids for COVID-19. ONHF can be insidious, manifesting with pain and limited movement, with magnetic resonance imaging (MRI) being the most effective diagnostic method. Treatment varies from conservative to surgical, depending on the stage of the disease. Early diagnosis and multidisciplinary follow-up are essential for a better prognosis. Future research should focus on developing COVID-19 treatment guidelines that reduce the incidence of ONCF, exploring safe and effective therapeutic alternatives.

Revista de MedicinaVol. 103(4)
Sociedade Brasileira de Ortopedia e Traumatologia (BR), Centro Universitário de Várzea Grande (BR), Santa Casa de Misericórdia de Passos (BR), Fundação Faculdade de Medicina (BR)
Good health and well-being
Openalex Percentile: Top 82%
Bone and Joint Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Osteonecrose da cabeça femoral por uso de corticosteroides no tratamento da COVID-19: relato de caso — Lucas Hiron Ulhoa Carvalho, Mateus Gonçalves de Sena Barbosa, et al. · Revista de Medicina (2024) | TGRS Research Map | TGRS